Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $359.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target boosted by Bank of America from $336.00 to $359.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on ALNY. Royal Bank Of Canada […]
More Stories
The Best Food Scene You Don’t Know About Is in Buffalo, New York
By Adam Reiner, Bloomberg News Buffalo might be synonymous with hot wings, but there’s a less heralded bar staple that...
The Best Food Scene You Don’t Know About Is in Buffalo, New York
By Adam Reiner, Bloomberg News Buffalo might be synonymous with hot wings, but there’s a less heralded bar staple that...
Your Brain’s Secret Defense Against Alzheimer’s
By Brendon Fallon and Lynn Xu For many people, Alzheimer’s disease casts an increasingly large shadow as mental fog, forgotten...
Your Brain’s Secret Defense Against Alzheimer’s
By Brendon Fallon and Lynn Xu For many people, Alzheimer’s disease casts an increasingly large shadow as mental fog, forgotten...
Rivian Recalls Nearly 35,000 Delivery Vans Over Seat Belt Misuse Issue
By Rob Sabo Electric vehicle (EV) manufacturer Rivian Automotive announced on Dec. 3 it is recalling 34,824 delivery vans due...
Rivian Recalls Nearly 35,000 Delivery Vans Over Seat Belt Misuse Issue
By Rob Sabo Electric vehicle (EV) manufacturer Rivian Automotive announced on Dec. 3 it is recalling 34,824 delivery vans due...